In June, an FDA advisory committee voted against approval of midomafetamine capsules (MDMA) for adults living with posttraumatic stress disorder (PTSD).
Giuliana Grossi
Advertisement
Articles by Giuliana Grossi
Advertisement
Latest Updated Articles
FDA Issues Complete Response Letter for MDMA-Assisted Therapy for PTSDPublished: August 12th 2024 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Cobenfy in Practice: Hope, Hurdles, and the Next Chapter in Schizophrenia Care
2
What’s New in the Diagnosis and Treatment of Headaches That Ophthalmologists Should Know About? | AAO 2025
3
Making Sense of the Eye Pain-Headache Connection | AAO 2025
4
AI in Ophthalmology: The Key to the Present Success Includes a CPT Code. The Future? Agentic AI That Doesn’t Wait To Be Told What To Do | AAO 2025
5
